AS men (n=41)

AS women (n=43)

Statistical significance

enteroSpA men (n=9)

Entero SpA women (n=31)

Statistical significance

Age (mean ±  sd)

42.1 ± 11.9

44.6 ±13.7

NS

47.8 ± 13.6

48.1 ±13.4

NS

Age at diagnosis (mean ±   sd) YEARS

37.3 ± 14

36.8 ±14.2

NS

41.8 ± 10

42.9 ±13.8

NS

Disease duration (mean ±  sd) YEARS

10.9 ± 9.5

12.9 ± 9.9

NS

6.6 ± 5.4

10.2 ±13.8

NS

Delay in diagnosis (mean ±  sd) YEARS

6.4 ± 5.5

7.7 ± 7.3

NS

0.4 ± 0.5

4.7 ± 6.3

0.005

Night pain (mean ±  sd) cm

6 ± 2.8

6.3 ± 2.8

NS

6.1 ± 3.7

5.8 ± 3.0

NS

BASDAI score

5.6 ± 1.7

6.7 ± 1.6

0.005

5.7 ± 2.3

5.5 ± 1.9

NS

ESR

12 ± 14.9

19.9 ±18.5

NS

14.5 ± 8.3

23.6 ±20.5

NS

CRP

8.6 ± 10.6

6.2 ± 4.1

NS

6.1 ± 3.9

12.5 ±16.5

NS

BASFI score

4.2 ± 2.5

5.3 ± 2.7

NS

4.8 ± 2.5

4.6 ± 3

NS

Wbw

5.5 ± 2.2

5.7 ± 2.9

NS

5.5 ± 2.3

5.6 ± 2.8

NS

Wb6m

6.3 ± 2.2

6.3 ± 2.6

NS

4.7 ± 3.3

6.6 ± 2.3

NS

AS: ankylosing spondylitis; EnteroSpA: enteropathic spondyloarthritis; CD: Crohn’s disease; UC: ulcerative colitis. M: males, F: females.
SD = standard deviation; ESR = erythrocyte sedimentation rate; CRP = C-reactive protein.
Wbw = well-being over the preceding week; Wb6m = well-being over the preceding 6 months.
Table 4: Demographic and clinical characteristics of the men and women with enteroSpA SpA or AS.